Last data update: May 13, 2024. (Total: 46773 publications since 2009)
Records 1-4 (of 4 Records) |
Query Trace: Barfield Wanda[original query] |
---|
Designing your patient's prenatal care "PATH": Recommendations for maternity care professionals based on MiPATH
Peahl AlexFriedman , Turrentine Mark , Barfield Wanda , Blackwell SeanC , Zahn ChristopherM . Contemp Ob Gyn 2022 67 (1) 27-30 The article provides recommendations for maternity care professionals when designing their patient's prenatal care Plan for Appropriate Tailored Healthcare (PATH). Topics discussed include evidence supporting prenatal care recommendations, information on Michigan PATH (MiPATH) panel process, and MiPATH panel recommendations which includes screening for medical, social, and structural determinants of health, telemedicine, and supporting for social and structural determinants. |
Association of Preterm Birth Rate With COVID-19 Statewide Stay-at-Home Orders in Tennessee.
Harvey EM , McNeer E , McDonald MF , Shapiro-Mendoza CK , Dupont WD , Barfield W , Patrick SW . JAMA Pediatr 2021 175 (6) 635-637 This cohort study analyzes preterm birth rates during statewide stay-at-home orders in Tennessee during the coronavirus disease 2019 (COVID-19) pandemic. |
Severe Coronavirus Infections in Pregnancy: A Systematic Review.
Galang RR , Chang K , Strid P , Snead MC , Woodworth KR , House LD , Perez M , Barfield WD , Meaney-Delman D , Jamieson DJ , Shapiro-Mendoza CK , Ellington SR . Obstet Gynecol 2020 136 (2) 262-272 OBJECTIVE: To inform the current coronavirus disease 2019 (COVID-19) outbreak, we conducted a systematic literature review of case reports of Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, during pregnancy and summarized clinical presentation, course of illness, and pregnancy and neonatal outcomes. DATA SOURCES: We searched MEDLINE and ClinicalTrials.gov from inception to April 23, 2020. METHODS OF STUDY SELECTION: We included articles reporting case-level data on MERS-CoV, SARS-CoV, and SARS-CoV-2 infection in pregnant women. Course of illness, indicators of severe illness, maternal health outcomes, and pregnancy outcomes were abstracted from included articles. TABULATION, INTEGRATION, AND RESULTS: We identified 1,328 unique articles, and 1,253 articles were excluded by title and abstract review. We completed full-text review on 75, and 29 articles were excluded by full-text review. Among 46 publications reporting case-level data, eight described 12 cases of MERS-CoV infection, seven described 17 cases of SARS-CoV infection, and 31 described 98 cases of SARS-CoV-2 infection. Clinical presentation and course of illness ranged from asymptomatic to severe fatal disease, similar to the general population of patients. Severe morbidity and mortality among women with MERS-CoV, SARS-CoV, or SARS-CoV-2 infection in pregnancy and adverse pregnancy outcomes, including pregnancy loss, preterm delivery, and laboratory evidence of vertical transmission, were reported. CONCLUSION: Understanding whether pregnant women may be at risk for adverse maternal and neonatal outcomes from severe coronavirus infections is imperative. Data from case reports of SARS-CoV, MERS-CoV, and SAR-CoV-2 infections during pregnancy are limited, but they may guide early public health actions and clinical decision-making for COVID-19 until more rigorous and systematically collected data are available. The capture of critical data is needed to better define how this infection affects pregnant women and neonates. This review was not registered with PROSPERO. |
Qualitative assessment of study materials and communication strategies used in studies that include DNA collection.
Jenkins MM , Reed-Gross E , Barfield WD , Prue CE , Gallagher ML , Rasmussen SA , Honein MA . Am J Med Genet A 2011 155A (11) 2721-31 To understand motivations and barriers to participation in studies that include DNA collection, focus group discussions were held with mothers who had participated in a case-control study of birth defects. Recruited mothers had completed an interview and had received a mailed kit containing cytobrushes to collect buccal cells for DNA from herself, her infant, and her infant's father. Six moderator-led focus groups were attended by a total of 38 women residing in Atlanta, Georgia. Focus groups were segmented by DNA collection status (biologics participants or nonparticipants), infant case-control status, infant birthweight, and maternal race and ethnicity. This report assesses maternal attitudes toward study materials and communication strategies. Across groups, respondents expressed concern about how their contact information was obtained. Study materials were described as clear and professional by most women, although some respondents reported confusion about disclosure of individual genetic results. Respondents generally reported that monetary incentives were not a motivation to participate, but increased perceived study legitimacy. Biologics nonparticipants expressed concerns about kit component sterility; government involvement; and DNA sample use, storage, and disposal. Respondents suggested that investigators provide feedback on whether sample collection was performed correctly and provide materials targeted to fathers to help alleviate paternal skepticism. Participation in DNA collection might be improved by strengthening study materials and communication strategies. Published 2011. This article is a U.S. Government work and is in the public domain in the USA. |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure